Deregulated Myc requires MondoA/Mlx for metabolic reprogramming and tumorigenesis
about
Metabolic vulnerabilities of MYC-induced cancerInteractions between Myc and MondoA transcription factors in metabolism and tumourigenesisMYC, Metabolism, and CancerOncogenes strike a balance between cellular growth and homeostasisMYC and metabolism on the path to cancerLatent KSHV Infected Endothelial Cells Are Glutamine Addicted and Require Glutaminolysis for SurvivalMenin enhances c-Myc-mediated transcription to promote cancer progressionGlobally Optimized Targeted Mass Spectrometry: Reliable Metabolomics Analysis with Broad CoverageCombining NMR and LC/MS Using Backward Variable Elimination: Metabolomics Analysis of Colorectal Cancer, Polyps, and Healthy Controls.Mechanisms and functions of Nrf2 signaling in Drosophila.Metabolomics method to comprehensively analyze amino acids in different domainsMetabolic reprogramming in triple-negative breast cancer through Myc suppression of TXNIPMYC oncogene overexpression drives renal cell carcinoma in a mouse model through glutamine metabolismTargeted plasma metabolome response to variations in dietary glycemic load in a randomized, controlled, crossover feeding trial in healthy adultsStrategies to Inhibit Myc and Their Clinical ApplicabilityThe glucose-sensing transcription factor MLX promotes myogenesis via myokine signalingMyc Depletion Induces a Pluripotent Dormant State Mimicking DiapausePhototransduction Influences Metabolic Flux and Nucleotide Metabolism in Mouse RetinaDriver or passenger effects of augmented c-Myc and Cdc20 in gliomagenesis.Multi-omics analyses reveal metabolic alterations regulated by hepatitis B virus core protein in hepatocellular carcinoma cells.Deregulated KLF4 Expression in Myeloid Leukemias Alters Cell Proliferation and Differentiation through MicroRNA and Gene Targets.How does metabolism affect cell death in cancer?Integration of ChREBP-Mediated Glucose Sensing into Whole Body Metabolism.The MYC mRNA 3'-UTR couples RNA polymerase II function to glutamine and ribonucleotide levels.Pharmacometabonomic Prediction of Busulfan Clearance in Hematopoetic Cell Transplant Recipients.Lactate-An Integrative Mirror of Cancer Metabolism.MYC, Metabolic Synthetic Lethality, and Cancer.Emerging tale of UPR and cancer: an essentiality for malignancy.MNT and Emerging Concepts of MNT-MYC AntagonismResetting cancer stem cell regulatory nodes upon MYC inhibition.The MYCN Protein in Health and Disease.Candidate serum metabolite biomarkers for differentiating gastroesophageal reflux disease, Barrett's esophagus, and high-grade dysplasia/esophageal adenocarcinoma.A novel role for the extended MYC network in cancer cell survival.MYC is a positive regulator of choline metabolism and impedes mitophagy-dependent necroptosis in diffuse large B-cell lymphoma.Genome-wide association study identifies novel type II diabetes risk loci in Jordan subpopulations.Allele-Specific Reprogramming of Cancer Metabolism by the Long Non-coding RNA CCAT2.Merkel cell polyomavirus recruits MYCL to the EP400 complex to promote oncogenesis.Oncogene KRAS activates fatty acid synthase, resulting in specific ERK and lipid signatures associated with lung adenocarcinoma.MYC and tumor metabolism: chicken and egg.Quantitative Method to Investigate the Balance between Metabolism and Proteome Biomass: Starting from Glycine.
P2860
Q26766855-8AAA6BF8-C5AF-4138-8C38-2BB0DD926ED7Q26782728-24468F51-778B-4771-A7D1-730F55BD3E13Q26783555-A953DB43-CF83-40FD-B209-8C4461A89741Q26798085-4E2EC36A-FFEA-4DE6-987C-A1BBC9F9A231Q26798086-21A0E55D-086E-47DE-8424-3B451F5FAECAQ28546705-08D0133F-C49B-486B-BA02-5DEFADA25A7FQ33654359-CCA7CDA4-9001-4BD8-89F1-4B03C15B0B96Q33707386-87E867A8-0A5C-44FB-948A-092428776061Q33745104-AF8CE9F6-1CAF-4EF4-BE16-5E74BA9D15D6Q33763536-97C21D66-DDE4-4848-95E8-C2AA7BE9C158Q35235756-CA545059-4E90-4D44-90F5-42B47FB29B1FQ35567021-1005C90A-C064-47EC-9250-11D0C65A6A15Q35669189-F8F6CD0C-F66E-4C7B-8032-EC2B06C08B7CQ36021394-DDE47014-64D6-47EB-97CC-2766429D4326Q36303678-9D2626BA-3E85-4C3F-9EFF-9D3210194BF0Q36406411-E33CDA6A-501B-4537-B569-F4D8A6651C25Q36577855-B77A92B1-8E85-4348-9E17-765D8E7ACAEAQ36744568-44063289-06B9-41C2-BCC6-FCDE7C33FA1FQ37269061-D2CF4C66-B00B-421E-BF30-5CA3206A1100Q37598554-19639BED-8098-4876-8949-92C715093DDAQ38384041-62C497F5-693D-4B05-8ED1-6DBC51F19886Q38615890-8A171C5D-7A08-4FD3-89D1-B56B659D984CQ38622648-C5D68AED-AEB6-4EDA-A794-9915B3E45CF1Q38707758-183E51C5-C832-40D4-8850-43F83CEB9A18Q38847841-F14312F8-C0BF-4906-A50E-A167B1AE4577Q38936245-DF5DA126-87DC-44CC-BC75-A5B57A062F5BQ38936255-E8DC45D0-FDC7-4503-BB27-83D4ECB8F7AEQ38954615-7FD903D1-6F3C-48E0-B302-1FBAF54E4071Q39147902-D2932D80-9DE4-4AF3-8767-A678DB651BDCQ39182602-538ABC0D-D67B-4164-9385-586EB4A0C094Q39208675-8254382A-4CFF-4954-AC00-08FAFAE7CB8BQ40338828-F27466CD-8003-441B-B388-9AD3C6FAD1C5Q40630141-9ED6C1F7-3561-4D5D-89BE-5A83707C8613Q41316559-8F259C27-522F-4E2B-AF9F-64DA4C07D055Q41463700-606BF338-5E73-4F62-9EF5-CDBE74198FF5Q42153434-BC68513D-0ED0-4A65-AFEA-950B43B1E39AQ42653330-A8C6A1D0-764A-4F55-9A27-2681FD9E2249Q43100869-66E6952F-5D50-47A5-B0D7-290C5D603F5FQ47414931-E84ABCC1-6423-4E5F-AE99-C4068E9AE079Q48217308-6779F666-DD8B-40F5-A29A-22D6DD2BC9D2
P2860
Deregulated Myc requires MondoA/Mlx for metabolic reprogramming and tumorigenesis
description
2015 nî lūn-bûn
@nan
2015 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
name
Deregulated Myc requires MondoA/Mlx for metabolic reprogramming and tumorigenesis
@ast
Deregulated Myc requires MondoA/Mlx for metabolic reprogramming and tumorigenesis
@en
type
label
Deregulated Myc requires MondoA/Mlx for metabolic reprogramming and tumorigenesis
@ast
Deregulated Myc requires MondoA/Mlx for metabolic reprogramming and tumorigenesis
@en
prefLabel
Deregulated Myc requires MondoA/Mlx for metabolic reprogramming and tumorigenesis
@ast
Deregulated Myc requires MondoA/Mlx for metabolic reprogramming and tumorigenesis
@en
P2093
P2860
P1433
P1476
Deregulated Myc requires MondoA/Mlx for metabolic reprogramming and tumorigenesis
@en
P2093
Daniel Diolaiti
Daniel Raftery
Danijel Djukovic
James B Hurley
Jianhai Du
Lisa McFerrin
Michelle Ulrich
Pei Feng Cheng
Robert N Eisenman
P2860
P304
P356
10.1016/J.CCELL.2014.11.024
P577
2015-01-29T00:00:00Z